Showing results (411-420 of 494) with videos related to

Sort By:
Pageof 50
Molecules (Basel, Switzerland)|March 24, 2016
Rhubarb Anthraquinones Protect Rats against Mercuric Chloride (HgCl₂)-Induced Acute Renal FailureDan Gao, Ling-Na Zeng, Pin Zhang, et al.
Orphanet Journal of Rare Diseases|June 20, 2022
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registryMichael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.
American Journal of Medical Genetics. Part A|April 28, 2009
Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004Hsiang-Yu Lin, Shuan-Pei Lin, Chih-Kuang Chuang, et al.
Orphanet Journal of Rare Diseases|July 23, 2014
Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)Hao-Chuan Liu, Hsiang-Yu Lin, Chia-Feng Yang, et al.
The Journal of Pediatrics|December 20, 2015
Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better OutcomesChia-Feng Yang, Chen Chang Yang, Hsuan-Chieh Liao, et al.
Clinical Kidney Journal|January 4, 2021
Fabry disease and COVID-19: international expert recommendations for management based on real-world experienceDawn A Laney, Dominique P Germain, João Paulo Oliveira, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|October 6, 2018
Predictors of poor outcomes in 488 patients with herb-induced liver injuryYun Zhu, Ming Niu, Jia-Bo Wang, et al.
Chinese Medicine|August 17, 2023
Yin/Yang associated differential responses to Psoralea corylifolia Linn. In rat models: an integrated metabolomics and transcriptomics studyMing-Liang Zhang, Xu Zhao, Wei-Xia Li, et al.
Frontiers in Medicine|September 20, 2023
Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi studyDaniel G Bichet, Robert J Hopkin, Patrício Aguiar, et al.
Cell Death & Disease|April 22, 2020
Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseasesWei Shi, Guang Xu, Xiaoyan Zhan, et al.
Pageof 50